Complementary and alternative medicine (CAM) use by patients enrolled in phase I clinical trials.

被引：0
|
作者：
Mandrekar, S [1 ]
Dy, GK [1 ]
Furth, A [1 ]
Bekele, L [1 ]
Hanson, L [1 ]
Sloan, J [1 ]
Adjei, AA [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8053
引用
收藏
页码：742S / 742S
页数：1
相关论文
共 50 条
  • [1] Complementary and alternative medicine use by patients enrolled onto phase I clinical trials
    Dy, GK
    Bekele, L
    Hanson, LJ
    Furth, A
    Mandrekar, S
    Sloan, JA
    Adjei, AA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4810 - 4815
  • [2] The use of complementary and alternative medicine (CAM) in cancer patients participating in clinical trials.
    Epelbaum, R
    Vizel, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 543S - 543S
  • [3] The use of complementary and alternative medicine in patients seen in phase I clinical trials program.
    Stephen, S.
    Naing, A.
    Hong, D. S.
    Fu, S.
    Wheler, J. J.
    Moulder, S. L.
    Falchook, G. S.
    Tsimberidou, A. M.
    Piha-Paul, S. A.
    Kurzrock, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Issues in clinical trials in complementary and alternative medicine (CAM)
    Pilapitiya, Senaka
    Siribaddana, Sisira
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 311 - 312
  • [5] Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials
    Wells, J. Connor
    Sidhu, Aven
    Ding, Keyue
    Smoragiewicz, Martin
    Heng, Daniel Y. C.
    Shepherd, Frances A.
    Ellis, Peter M.
    Bradbury, Penelope A.
    Jonker, Derek J.
    Siu, Lillian L.
    Gelmon, Karen A.
    Karapetis, Christos
    Shapiro, Jeremy
    Nott, Louise
    O'Callaghan, Christopher J.
    Parulekar, Wendy R.
    Seymour, Lesley
    Monzon, Jose G.
    ONCOLOGIST, 2022, 27 (03): : E286 - E293
  • [6] Survival and clinical outcomes of ovarian cancer patients enrolled in phase I clinical trials.
    Corr, Bradley
    Moroney, Marisa
    Sheeder, Jeanelle
    Sawyer, Brandon
    Eckhardt, S. Gail
    Behbakht, Kian
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] The use of complementary and alternative medicine (CAM) in sarcoma patients
    Sungu-Winkler, K-T.
    Huebner, J.
    Menge, F.
    Kasper, B.
    Hohenberger, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Complementary and Alternative Medicine Use in Patients Enrolled in Gastroparesis Registry
    Lee, Linda A.
    Unalp, Aynur
    Corless, Erin
    Yates, Katherine P.
    Parkman, Henry P.
    Abell, Thomas L.
    Koch, Kenneth L.
    Hasler, William L.
    Pasricha, Pankaj J.
    Snape, William J.
    Nguyen, Linda T.
    McCallum, Richard W.
    Sarosiek, Irene
    Farrugia, Gianrico
    Tonascia, James
    Hamilton, Frank A.
    GASTROENTEROLOGY, 2013, 144 (05) : S740 - S740
  • [9] THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM)
    Fonnebo, K.
    Launso, L.
    Grimsgaard, S.
    Salamonsen, A.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3488 - 3489
  • [10] Predictive score of early mortality in patients with solid tumors enrolled in phase I clinical trials.
    Ugidos, Lisardo
    Boni, Valentina
    Garralda, Elena
    Luken, Maria Jose de Miguel
    Alvarez-Gallego, Rafael
    Rodriguez-Pascual, Jesus
    Vega, Estela
    Munoz, Cesar
    Garcia-Rey, Cesar
    Cubillo, Antonio
    Calvo, Emiliano
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345